In what plaintiffs' lawyers are calling a "radical" move, House Republicans are pushing for a measure that would give immunity in products-liability cases to pharmaceutical manufacturers so long as a drug was approved by the Federal Drug Administration. The provision says that no manufacturer or seller shall be held liable in a products-liability action so long as the product was designed, manufactured, packaged and sold in accordance with the terms of an approval of a government agency.
Tagged with: FDA General Assembly Legislature Pharmaceutical Products Liability
Read More »